![Frank Hensel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frank Hensel
Directeur/Membre du Conseil chez
Mecuris GmbH
Profil
Frank Hensel is the founder of OncoMab GmbH, which was founded in 2002.
He held the title of Chief Executive Officer from 2002 to 2007.
Currently, Dr. Hensel is working as a Principal & Authorized Signatory at High-Tech Gründerfonds Management GmbH since 2015 and as a Board Member at Mecuris GmbH since 2018.
In his former positions, he worked as the Managing Director at Patrys GmbH, Vice President-Research & Development at Patrys Ltd., and as a Board Member at SciRhom GmbH from 2016 to 2020.
Dr. Hensel completed his graduate degree at the University of Osnabrück in 1994 and obtained his doctorate degree from Julius-Maximilians-Universität Würzburg in 1998.
Postes actifs de Frank Hensel
| Sociétés | Poste | Début |
|---|---|---|
Mecuris GmbH
 Mecuris GmbH Medical SpecialtiesHealth Technology Manufactures and supplies orthopedic aids through web platform & 3d printing techniques | Directeur/Membre du Conseil | 01/08/2018 |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Private Equity Investor | 01/01/2015 |
Anciens postes connus de Frank Hensel
| Sociétés | Poste | Fin |
|---|---|---|
SciRhom GmbH
 SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Directeur/Membre du Conseil | 31/03/2020 |
Patrys GmbH | Directeur Général | 30/11/2015 |
OncoMab GmbH
 OncoMab GmbH Medical DistributorsDistribution Services Develops and markets human antibodies for cancer therapy | Fondateur | 31/01/2007 |
| PATRYS LIMITED | Directeur Technique/Scientifique/R&D | - |
Formation de Frank Hensel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
University of Osnabrück
 University of Osnabrück Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoMab GmbH
OncoMab GmbH Medical DistributorsDistribution Services Develops and markets human antibodies for cancer therapy | Distribution Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Finance |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patrys GmbH | |
Mecuris GmbH
Mecuris GmbH Medical SpecialtiesHealth Technology Manufactures and supplies orthopedic aids through web platform & 3d printing techniques | Health Technology |
SciRhom GmbH
SciRhom GmbH BiotechnologyHealth Technology Operates as a pioneering biotech enterprise specialized in developing therapeutic antibodies | Health Technology |
